Transitional Cell Carcinoma — Research

Transitional Cell Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	23,381	`("Carcinoma, Transitional Cell"[mh] OR "Cell Carcinoma, Transitional"[mh])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	4,089	`("Carcinoma, Transitional Cell"[mh] OR "Cell Carcinoma, Transitional"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	568	`("Carcinoma, Transitional Cell"[mh] OR "Cell Carcinoma, Transitional"[mh]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (34)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 34 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
· N Engl J Med · 2019 · PMID 31340094 · validated civic_curation pubmed
The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.
· Cancer Epidemiol Biomarkers Prev · 2005 · PMID 15824158 · validated civic_curation pubmed
Genome sequencing identifies a basis for everolimus sensitivity.
· Science · 2012 · PMID 22923433 · validated civic_curation pubmed
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.
· J Clin Oncol · 2016 · PMID 27044931